11/9/2024

Epinephrine Auto-Injectors

Products Affected - Description

- EpiPen injection, Mylan (Viatris), 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 49502-0500-02
- EpiPen Jr injection, Mylan (Viatris), 0.15 mg/0.3 mL, auto-injector, 2 count, NDC 49502-0501-02
- Symjepi injection, Sandoz, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 00781-3442-20 - discontinued
- Symjepi injection, US WorldMeds, LLC, 0.15 mg/0.3 mL, auto-injector, 2 count, NDC 78670-0131-02
- Symjepi injection, US WorldMeds, LLC, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 78670-0130-02
- Epinephrine injection, Teva, 0.15 mg/0.3 mL, auto-injector, 2 count, NDC 00093-5985-27

Reason for the Shortage

- Amneal has epinephrine auto-injectors available.
- Kaleo has Auvi-Q available only through specific distributors.
- Mylan did not provide a reason for the shortage of EpiPen and EpiPen Jr.
- Teva did not provide a reason for the shortage of epinephrine 0.15 mg/0.3 mL auto-injectors. Tevas has epinephrine 0.3 mg/0.3 mL auto-injectors available.
- In March 2022, certain lots of Symjepi were recalled due to potential clogging of the needle. US Worldmeds states the shortage is due to ongoing issues related to the recall.

Available Products

- Auvi-Q injection, Kaleo, 0.1 mg/0.1 mL, auto-injector, 2 count, NDC 60842-0021-01
- Auvi-Q injection, Kaleo, 0.15 mg/0.15 mL, auto-injector, 2 count, NDC 60842-0022-01
- Auvi-Q injection, Kaleo, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 60842-0023-01
- Epinephrine injection, Amneal, 0.15 mg/0.15 mL, auto-injector, 2 count, NDC 00115-1695-49
- Epinephrine injection, Amneal, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 00115-1694-49
- Epinephrine injection, Mylan (Viatris), 0.15 mg/0.3 mL, auto-injector, 2 count, NDC 49502-0101-02
- Epinephrine injection, Mylan (Viatris), 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 49502-0102-02
- Epinephrine injection, Teva, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 00093-5986-27

Estimated Resupply Dates

- Mylan has EpiPen and EpiPen Jr auto-injectors on back order and the company cannot estimate a release date.
- Teva has epinephrine injection 0.15 mg/0.3 mL auto-injectors on back order and the company estimates a release date in early-November 2024.
- US Worldmeds has Symjepi auto-injectors on back order and the company cannot estimate a release date.

Updated

Updated November 9, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created May 3, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.